Zobrazeno 1 - 10
of 11
pro vyhledávání: '"S L M A Beeres"'
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Leiden University Medical Center Background Hospitalizations for decompensated heart failure are a marker for poor prognosis and pose a burden on patients a
Autor:
Jasper J Brugts, Sumant P Radhoe, Pascal R D Clephas, Dilan Aydin, Marco W F van Gent, Mariusz K Szymanski, Michiel Rienstra, Mieke H van den Heuvel, Carlos A da Fonseca, Gerard C M Linssen, C Jan Willem Borleffs, Eric Boersma, Folkert W Asselbergs, Arend Mosterd, Hans-Peter Brunner-La Rocca, Rudolf A de Boer, M E Emans, S L M A Beeres, L Heerebeek, C Kirchhof, J Van Ramshorst, R Spee, T Smilde, M Van Eck, E Kaplan, R Hazeleger, R Tukkie, M Feenema, W Kok, V Van Halm, M L Handoko, R Van Kimmenade, M Post, N Van Mieghem, O C Manintveld
Publikováno v:
The Lancet.
Publikováno v:
European Heart Journal. 43
Background Continuous-flow left ventricular assist device (CF-LVAD) patients require anticoagulation with vitamin K antagonists (VKAs). Good versus suboptimal anticoagulation control expressed as high versus low time in target range (TTR) of internat
Autor:
M Feijen, M Beles, Y Z Than, A Cordon, M Dupont, R W Treskes, M Caputo, W Mullens, K Van Bokstal, A Auricchio, A D Egorova, E Maes, S L M A Beeres, W A Heggermont
Publikováno v:
European Heart Journal. 43
Background Hospitalization for decompensated heart failure may be prevented by early detection of fluid retention. The multisensory HeartLogic™ algorithm, incorporated in a cardiac implantable electronic device (CIED) aims to detect impending fluid
Autor:
N. E. van Hattem, S. L. M. A. Beeres, B. J. A. Mertens, M. L. Antoni, D. E. Atsma, M. J. Schalij, M. C. den Haan
Publikováno v:
Netherlands Heart Journal. BOHN STAFLEU VAN LOGHUM BV
Netherlands Heart Journal
Netherlands Heart Journal
Introduction Hospital admissions for heart failure (HF) are frequent and pose a heavy burden on health care resources. Currently, the decision to hospitalise is based on clinical judgement rather than on prognostic risk stratification. The Emergency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b881c757f2bf9628a4d7c1fa989a38
https://link.springer.com/article/10.1007/s12471-022-01661-3
https://link.springer.com/article/10.1007/s12471-022-01661-3
Publikováno v:
Netherlands Heart Journal
Netherlands Heart Journal, 30(2), 76-83. BOHN STAFLEU VAN LOGHUM BV
Netherlands Heart Journal, 30(2), 76-83. BOHN STAFLEU VAN LOGHUM BV
In the Netherlands, the coronavirus disease 2019 (COVID‑19) pandemic has resulted in excess mortality nationwide. Chronic heart disease patients are at risk for a complicated COVID‑19 course. The current study investigates all-cause mortality amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79cc2e8527aa410a685f183ebc8684d4
https://hdl.handle.net/1887/3567800
https://hdl.handle.net/1887/3567800
Autor:
S L M A, Beeres
Publikováno v:
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 12(Suppl 2)
Autor:
S L M A, Beeres
Publikováno v:
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 13(Suppl 2)
Autor:
E R Holman, S A Mollema, J. van Ramshorst, D E Atsma, E. E. van der Wall, M.J. Schalij, J.J. Bax, N Ajmone Marsan, S L M A Beeres
Publikováno v:
Heart (British Cardiac Society). 95(2)
To evaluate the effect of bone marrow cell injection on global strain and left ventricular (LV) dyssynchrony.In 14 patients with severe postinfarction heart failure, 93 (14) x 10(6) autologous bone marrow cells were percutaneously injected in the inf
Autor:
S L M A, Beeres, J J, Bax, M P M, Stokkel, W E, Fibbe, E E, van der Wall, M J, Schalij, D E, Atsma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 150(27)
For a 74-year-old man with angina pectoris and demonstrated myocardial ischaemia, optimal medical treatment was insufficient. He was ineligible for coronary revascularization. To improve myocardial perfusion, autologous bone-marrow stem cells were in